The pharmaceutical landscape is witnessing a change with the arrival of GLP-1 transdermal systems . These cutting-edge formulations offer a promising method to administering glucagon-like peptide-1 medication for individuals living with type 2 diabetes . Instead of daily shots , a easy-to-use pat